NL-OMON38118已完成不适用
Erythrocyte-bound apolipoprotein B after withdrawal of statin therapy - EBABAST
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Aged 18 years or older
- •Use of statin therapy
排除标准
- •A cardiovascular event (myocardial infarction, percutaneous coronary intervention or stroke) in the past 6 months.
- •The use of any other lipid lowering drugs besides a statin, for example ezetimibe or a fibrate in the past 6 months.
研究者
相似试验
已完成
不适用
Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin TherapyAtherosclerosisHyperlipidemiaNCT01634906Sint Franciscus Gasthuis55
已完成
不适用
Erythrocyte-bound apolipoprotein B in diabetes mellitusartherosclerosis1001842410003216DiabetesNL-OMON43369Sint Franciscus Gasthuis133
尚未招募
1 期
Apolipoprotein E driven therapeutics for Alzheimer’s diseaseAlzheimer's DiseaseACTRN12613000465752uclear Medicine and Centre for PET Research Fund20
已完成
不适用
Hepatitis B immunoglobulin (HBIg) withdrawal from combination lamivudine (LAM)/HBIg prophylaxis in liver transplant recipientsHepatitis B virus infected liver transplant recipientsInfections and InfestationsISRCTN52111708niversity of Birmingham (UK)120
招募中
不适用
Ondezoek naar de aanmaak en afbraak van cholesterolvetdeeltjes in patiënten met familiaire hypercholesterolemieFamilial hypercholesterolemia (FH), Cholestorol, Low-density lipoprotein (LDL), very low-density lipoproteien (VLDL), apolipoprotein (ApoB), kinetics.NL-OMON26254Academisch Medisch Centrum (AMC), Amsterdam60